Particularly, CBF/MYH11+ AML progenitors showed an almost exclusive immunophenotypic signature, as well as several characteristic LAIPs that were found in other molecular subtypes, such as KMT2A, PML-RARa and NPM1. Here, CEBPZ is linked to acute myeloid leukemia.